GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Betta Pharmaceuticals Co Ltd (SZSE:300558) » Definitions » Market Cap

Betta Pharmaceuticals Co (SZSE:300558) Market Cap : ¥15,936 Mil (As of Jun. 05, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Betta Pharmaceuticals Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Betta Pharmaceuticals Co's share price for the quarter that ended in Mar. 2024 was ¥40.92. Betta Pharmaceuticals Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 418 Mil. Therefore, Betta Pharmaceuticals Co's market cap for the quarter that ended in Mar. 2024 was ¥17,124 Mil.

Betta Pharmaceuticals Co's quarterly market cap declined from Sep. 2023 (¥23,971 Mil) to Dec. 2023 (¥21,573 Mil) and declined from Dec. 2023 (¥21,573 Mil) to Mar. 2024 (¥17,124 Mil).

Betta Pharmaceuticals Co's annual market cap declined from Dec. 2021 (¥33,161 Mil) to Dec. 2022 (¥20,569 Mil) but then increased from Dec. 2022 (¥20,569 Mil) to Dec. 2023 (¥21,573 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Betta Pharmaceuticals Co's Enterprise Value for Today is ¥17,994 Mil.


Betta Pharmaceuticals Co Market Cap Historical Data

The historical data trend for Betta Pharmaceuticals Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Betta Pharmaceuticals Co Market Cap Chart

Betta Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26,345.70 44,361.31 33,160.50 20,568.60 21,572.95

Betta Pharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24,530.36 20,050.94 23,970.88 21,572.95 17,124.45

Competitive Comparison of Betta Pharmaceuticals Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Betta Pharmaceuticals Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Betta Pharmaceuticals Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Betta Pharmaceuticals Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Betta Pharmaceuticals Co's Market Cap falls into.



Betta Pharmaceuticals Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Betta Pharmaceuticals Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥51.55*418.486
=¥21,573

Betta Pharmaceuticals Co's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=¥40.92*418.486
=¥17,124

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Betta Pharmaceuticals Co  (SZSE:300558) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Betta Pharmaceuticals Co Market Cap Related Terms

Thank you for viewing the detailed overview of Betta Pharmaceuticals Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Betta Pharmaceuticals Co (SZSE:300558) Business Description

Traded in Other Exchanges
N/A
Address
No.355, Xingzhong Road, Yuhang Economic and Technological Development Zone, Zhejiang Province, Hangzhou, CHN
Betta Pharmaceuticals Co Ltd is a hi-tech pharmaceutical enterprise focuses on research and development of innovative medicines. The company's drug is used for various diseases such as malignant tumors, diabetes, and cardio-cerebrovascular disease. Further, it offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used for the treatment of non-small-cell lung cancer. Geographically, the group operates through China.
Executives
Wang Jia Bing Directors, executives
Ding Lie Ming Directors, executives
Cai Wan Yu Executives

Betta Pharmaceuticals Co (SZSE:300558) Headlines

No Headlines